Thalidomide therapy for low-risk Myelodysplasia

Leuk Res. 2005 Feb;29(2):235-6. doi: 10.1016/j.leukres.2004.05.017.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Risk
  • Thalidomide / therapeutic use*

Substances

  • Antineoplastic Agents
  • Thalidomide